 | • レポートコード：D005-00775 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、中咽頭癌用診断及び治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。中咽頭癌用診断及び治療の種類別市場規模（内視鏡、生検、イメージング）、用途別市場規模（病院、外来手術センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、AB Science、VLPbio、GE Healthcare、Inovio Pharmaceuticals、Synta Pharmaceuticals、Bristol-Myers Squibb、Immunovaccine、Novartis、Bayer、Boston Biomedical、AstraZeneca ・地域別グローバル市場分析 2015年-2020年 ・中咽頭癌用診断及び治療の北米市場（アメリカ、カナダ、メキシコ） ・中咽頭癌用診断及び治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・中咽頭癌用診断及び治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・中咽頭癌用診断及び治療の南米市場（ブラジル、アルゼンチン） ・中咽頭癌用診断及び治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：内視鏡、生検、イメージング ・用途別分析：病院、外来手術センター ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Oropharyngeal Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Oropharyngeal Cancer Diagnosis and Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Oropharyngeal Cancer Diagnosis and Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oropharyngeal Cancer Diagnosis and Therapeutics market has been segmented into:
Endoscopy
Biopsy
Imaging
By Application, Oropharyngeal Cancer Diagnosis and Therapeutics has been segmented into:
Hospitals
Ambulatory surgery centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oropharyngeal Cancer Diagnosis and Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Oropharyngeal Cancer Diagnosis and Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oropharyngeal Cancer Diagnosis and Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Oropharyngeal Cancer Diagnosis and Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Oropharyngeal Cancer Diagnosis and Therapeutics Market Share Analysis
Oropharyngeal Cancer Diagnosis and Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oropharyngeal Cancer Diagnosis and Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oropharyngeal Cancer Diagnosis and Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Oropharyngeal Cancer Diagnosis and Therapeutics are:
Merck
AB Science
VLPbio
GE Healthcare
Inovio Pharmaceuticals
Synta Pharmaceuticals
Bristol-Myers Squibb
Immunovaccine
Novartis
Bayer
Boston Biomedical
AstraZeneca
Table of Contents
1 Oropharyngeal Cancer Diagnosis and Therapeutics Market Overview
1.1 Product Overview and Scope of Oropharyngeal Cancer Diagnosis and Therapeutics
1.2 Classification of Oropharyngeal Cancer Diagnosis and Therapeutics by Type
1.2.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Type in 2019
1.2.3 Endoscopy
1.2.4 Biopsy
1.2.5 Imaging
1.3 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Application
1.3.1 Overview: Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory surgery centers
1.4 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Regions
1.4.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Oropharyngeal Cancer Diagnosis and Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Oropharyngeal Cancer Diagnosis and Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Oropharyngeal Cancer Diagnosis and Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oropharyngeal Cancer Diagnosis and Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Oropharyngeal Cancer Diagnosis and Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oropharyngeal Cancer Diagnosis and Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 AB Science
2.2.1 AB Science Details
2.2.2 AB Science Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AB Science SWOT Analysis
2.2.4 AB Science Product and Services
2.2.5 AB Science Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 VLPbio
2.3.1 VLPbio Details
2.3.2 VLPbio Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 VLPbio SWOT Analysis
2.3.4 VLPbio Product and Services
2.3.5 VLPbio Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 GE Healthcare
2.4.1 GE Healthcare Details
2.4.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GE Healthcare SWOT Analysis
2.4.4 GE Healthcare Product and Services
2.4.5 GE Healthcare Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Inovio Pharmaceuticals
2.5.1 Inovio Pharmaceuticals Details
2.5.2 Inovio Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Inovio Pharmaceuticals SWOT Analysis
2.5.4 Inovio Pharmaceuticals Product and Services
2.5.5 Inovio Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Synta Pharmaceuticals
2.6.1 Synta Pharmaceuticals Details
2.6.2 Synta Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Synta Pharmaceuticals SWOT Analysis
2.6.4 Synta Pharmaceuticals Product and Services
2.6.5 Synta Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bristol-Myers Squibb
2.7.1 Bristol-Myers Squibb Details
2.7.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bristol-Myers Squibb SWOT Analysis
2.7.4 Bristol-Myers Squibb Product and Services
2.7.5 Bristol-Myers Squibb Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Immunovaccine
2.8.1 Immunovaccine Details
2.8.2 Immunovaccine Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Immunovaccine SWOT Analysis
2.8.4 Immunovaccine Product and Services
2.8.5 Immunovaccine Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis SWOT Analysis
2.9.4 Novartis Product and Services
2.9.5 Novartis Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bayer SWOT Analysis
2.10.4 Bayer Product and Services
2.10.5 Bayer Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Boston Biomedical
2.11.1 Boston Biomedical Details
2.11.2 Boston Biomedical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Boston Biomedical SWOT Analysis
2.11.4 Boston Biomedical Product and Services
2.11.5 Boston Biomedical Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.12 AstraZeneca
2.12.1 AstraZeneca Details
2.12.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 AstraZeneca SWOT Analysis
2.12.4 AstraZeneca Product and Services
2.12.5 AstraZeneca Oropharyngeal Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Oropharyngeal Cancer Diagnosis and Therapeutics Players Market Share
3.2.2 Top 10 Oropharyngeal Cancer Diagnosis and Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Market Share by Regions
4.2 North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Countries
5.1 North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Countries (2015-2020)
5.2 USA Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Countries
6.1 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Countries
7.1 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Countries (2015-2020)
7.2 China Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Countries
8.1 South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Oropharyngeal Cancer Diagnosis and Therapeutics by Countries
9.1 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Forecast by Type (2019-2024)
10.3 Endoscopy Revenue Growth Rate (2015-2025)
10.4 Biopsy Revenue Growth Rate (2015-2025)
10.5 Imaging Revenue Growth Rate (2015-2025)
11 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Segment by Application
11.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Oropharyngeal Cancer Diagnosis and Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory surgery centers Revenue Growth (2015-2020)
12 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size Forecast (2021-2025)
12.1 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size Forecast (2021-2025)
12.2 Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oropharyngeal Cancer Diagnosis and Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Merck Corporate Information, Location and Competitors
Table 6. Merck Oropharyngeal Cancer Diagnosis and Therapeutics Major Business
Table 7. Merck Oropharyngeal Cancer Diagnosis and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Merck SWOT Analysis
Table 9. Merck Oropharyngeal Cancer Diagnosis and Therapeutics Product and Solutions
Table 10. Merck Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. AB Science Corporate Information, Location and Competitors
Table 12. AB Science Oropharyngeal Cancer Diagnosis and Therapeutics Major Business
Table 13. AB Science Oropharyngeal Cancer Diagnosis and Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. AB Science SWOT Analysis
Table 15. AB Science Oropharyngeal Cancer Diagnosis and Therapeutics Product and Solutions
Table 16. AB Science Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. VLPbio Corporate Information, Location and Competitors
Table 18. VLPbio Oropharyngeal Cancer Diagnosis and Therapeutics Major Business
Table 19. VLPbio Oropharyngeal Cancer Diagnosis and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. VLPbio SWOT Analysis
Table 21. VLPbio Oropharyngeal Cancer Diagnosis and Therapeutics Product and Solutions
Table 22. VLPbio Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. GE Healthcare Corporate Information, Location and Competitors
Table 24. GE Healthcare Oropharyngeal Cancer Diagnosis and Therapeutics Major Business
Table 25. GE Healthcare Oropharyngeal Cancer Diagnosis and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. GE Healthcare SWOT Analysis
Table 27. GE Healthcare Oropharyngeal Cancer Diagnosis and Therapeutics Product and Solutions
Table 28. GE Healthcare Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Inovio Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Inovio Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Major Business
Table 31. Inovio Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Inovio Pharmaceuticals SWOT Analysis
Table 33. Inovio Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Product and Solutions
Table 34. Inovio Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Synta Pharmaceuticals Corporate Information, Location and Competitors
Table 36. Synta Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Major Business
Table 37. Synta Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Synta Pharmaceuticals SWOT Analysis
Table 39. Synta Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Product and Solutions
Table 40. Synta Pharmaceuticals Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 42. Bristol-Myers Squibb Oropharyngeal Cancer Diagnosis and Therapeutics Major Business
Table 43. Bristol-Myers Squibb Oropharyngeal Cancer Diagnosis and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Bristol-Myers Squibb SWOT Analysis
Table 45. Bristol-Myers Squibb Oropharyngeal Cancer Diagnosis and Therapeutics Product and Solutions
Table 46. Bristol-Myers Squibb Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Immunovaccine Corporate Information, Location and Competitors
Table 48. Immunovaccine Oropharyngeal Cancer Diagnosis and Therapeutics Major Business
Table 49. Immunovaccine Oropharyngeal Cancer Diagnosis and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Immunovaccine SWOT Analysis
Table 51. Immunovaccine Oropharyngeal Cancer Diagnosis and Therapeutics Product and Solutions
Table 52. Immunovaccine Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Novartis Corporate Information, Location and Competitors
Table 54. Novartis Oropharyngeal Cancer Diagnosis and Therapeutics Major Business
Table 55. Novartis Oropharyngeal Cancer Diagnosis and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. Novartis SWOT Analysis
Table 57. Novartis Oropharyngeal Cancer Diagnosis and Therapeutics Product and Solutions
Table 58. Novartis Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bayer Corporate Information, Location and Competitors
Table 60. Bayer Oropharyngeal Cancer Diagnosis and Therapeutics Major Business
Table 61. Bayer Oropharyngeal Cancer Diagnosis and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 62. Bayer SWOT Analysis
Table 63. Bayer Oropharyngeal Cancer Diagnosis and Therapeutics Product and Solutions
Table 64. Bayer Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Boston Biomedical Corporate Information, Location and Competitors
Table 66. Boston Biomedical Oropharyngeal Cancer Diagnosis and Therapeutics Major Business
Table 67. Boston Biomedical Oropharyngeal Cancer Diagnosis and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 68. Boston Biomedical SWOT Analysis
Table 69. Boston Biomedical Oropharyngeal Cancer Diagnosis and Therapeutics Product and Solutions
Table 70. Boston Biomedical Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. AstraZeneca Corporate Information, Location and Competitors
Table 72. AstraZeneca Oropharyngeal Cancer Diagnosis and Therapeutics Major Business
Table 73. AstraZeneca Oropharyngeal Cancer Diagnosis and Therapeutics Total Revenue (USD Million) (2017-2018)
Table 74. AstraZeneca SWOT Analysis
Table 75. AstraZeneca Oropharyngeal Cancer Diagnosis and Therapeutics Product and Solutions
Table 76. AstraZeneca Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 78. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Share by Players (2015-2020)
Table 79. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Regions (2015-2020)
Table 81. North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Countries (2015-2020)
Table 82. North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Countries (2015-2020)
Table 83. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Countries (2015-2020)
Table 86. South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Countries (2015-2020)
Table 89. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 90. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Share by Type (2015-2020)
Table 91. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Forecast by Type (2021-2025)
Table 92. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue by Application (2015-2020)
Table 93. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Share by Application (2015-2020)
Table 94. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Forecast by Application (2021-2025)
Table 95. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Oropharyngeal Cancer Diagnosis and Therapeutics Picture
Figure 2. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Type in 2019
Figure 3. Endoscopy Picture
Figure 4. Biopsy Picture
Figure 5. Imaging Picture
Figure 6. Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Ambulatory surgery centers Picture
Figure 9. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share in 2019
Figure 18. Global Top 10 Players Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 22. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Regions in 2018
Figure 23. North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 24. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 29. North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Countries in 2019
Figure 30. USA Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. Canada Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Countries in 2019
Figure 35. Germany Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. UK Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. France Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. Russia Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. Italy Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Countries in 2019
Figure 42. China Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Japan Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Korea Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. India Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 48. South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Countries in 2019
Figure 49. Brazil Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. UAE Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Share by Type (2015-2020)
Figure 58. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Share by Type in 2019
Figure 59. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share Forecast by Type (2021-2025)
Figure 60. Global Endoscopy Revenue Growth Rate (2015-2020)
Figure 61. Global Biopsy Revenue Growth Rate (2015-2020)
Figure 62. Global Imaging Revenue Growth Rate (2015-2020)
Figure 63. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Share by Application (2015-2020)
Figure 64. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Share by Application in 2019
Figure 65. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 67. Global Ambulatory surgery centers Revenue Growth Rate (2015-2020)
Figure 68. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Forecast (2021-2025)
Figure 72. Europe Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Forecast (2021-2025)
Figure 74. South America Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Oropharyngeal Cancer Diagnosis and Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
大腸がん診断＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Colorectal Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …- 骨がん診断・治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bone Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bone C…
- 肺がん診断及び治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Lung Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lung C…
- 皮膚がん診断・治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Skin Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Skin C…
- 去勢抵抗性前立腺がん（CRPC）/ HRPCA治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.9% in the forecast period of 2020 to 2025 and will expected to reach USD 9300.5 million by 2025, from USD 7…